Allergen immunotherapy in allergic rhinitis: current use and future trends
L Klimek, O Pfaar, J Bousquet, G Senti… - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Type-1 allergies are among the most chronic common diseases of humans.
Allergen immunotherapy (AIT) is the only causative and disease-modifying treatment option …
Allergen immunotherapy (AIT) is the only causative and disease-modifying treatment option …
[HTML][HTML] Specific immunotherapy—indications and mode of action
R Brehler, L Klimek, MV Kopp… - Deutsches Ärzteblatt …, 2013 - ncbi.nlm.nih.gov
Background It is estimated that up to 24% of the population in Germany suffers from allergic
rhinoconjunctivitis and 5% from allergic asthma. Allergic rhinoconjunctivitis is closely related …
rhinoconjunctivitis and 5% from allergic asthma. Allergic rhinoconjunctivitis is closely related …
A comparison of immunotherapy delivery methods for allergen immunotherapy
L Klimek, O Pfaar - Expert review of clinical immunology, 2013 - Taylor & Francis
Background: Allergic diseases are among the most common diseases in humans. Besides
allergen avoidance, allergen-specific immunotherapy is the only causative treatment option …
allergen avoidance, allergen-specific immunotherapy is the only causative treatment option …
Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids – differences in vivo and in vitro
B Heydenreich, I Bellinghausen, L Lund… - Clinical & …, 2014 - academic.oup.com
Allergen-specific immunotherapy (SIT) is a clinically effective therapy for immunoglobulin
(Ig) E-mediated allergic diseases. To reduce the risk of IgE-mediated side effects, chemically …
(Ig) E-mediated allergic diseases. To reduce the risk of IgE-mediated side effects, chemically …
Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass …
J Kleine-Tebbe, M Walmar, K Bitsch-Jensen… - Clinical drug …, 2014 - Springer
Objective Specific immunotherapy is the only treatment for the underlying allergic disease in
patients with respiratory allergies. The primary objective of this trial was to evaluate the …
patients with respiratory allergies. The primary objective of this trial was to evaluate the …
Recent advances in immunotherapy for allergic diseases
D El-Qutob, G Mencia… - Recent patents on …, 2014 - ingentaconnect.com
Allergic diseases are a major health problem worldwide. The therapeutic approaches to
treat allergic rhinitis (AR) and allergic asthma (AA) fall in three major categories. The first …
treat allergic rhinitis (AR) and allergic asthma (AA) fall in three major categories. The first …
[PDF][PDF] Desarrollo de la formulación, escalado y estabilidad de la vacuna antialérgica de Dermatophagoides siboney adyuvada con gel de hidróxido de aluminio
R Samalea-Díaz, D Torralba-Averoff… - Revista CENIC …, 2018 - redalyc.org
La adsorción de las proteínas alergénicas al gel de hidróxido de aluminio (GHA) es
importante para la seguridad y efectividad de las vacunas empleadas para la inmunoterapia …
importante para la seguridad y efectividad de las vacunas empleadas para la inmunoterapia …
Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy
A Mari, M Antonietta Ciardiello… - Clinical & …, 2013 - Wiley Online Library
In 2012, we received 683 submissions and published 20 editorials, 38 reviews, 11 letters
and 128 original articles. This represents an acceptance rate for original papers in the range …
and 128 original articles. This represents an acceptance rate for original papers in the range …
[HTML][HTML] Novel Approaches of Immunotherapy
JR Stokes, TB Casale - Current Treatment Options in Allergy, 2014 - Springer
Opinion statement Allergic diseases affect millions of adults and children in the United
States. Allergen immunotherapy has been a treatment option for diseases such as allergic …
States. Allergen immunotherapy has been a treatment option for diseases such as allergic …